TCRX

0.14360.63%
SR

Stephen Richard Biggar

Independent Director

Dr. Stephen Richard Biggar, M.D. Ph.D. is a Director of Notch Therapeutics Inc. and Precision Neuroscience Corporation. He is Independent Director at TScan Therapeutics, Inc. since March 2021 and serves as its Chair of the Board since June 2024. He served as Director at Neurogene Inc. He is a Principal of Baker Brothers Investments. Dr. Biggar was a Partner at Baker Bros. Advisors LP which he joined in 2000. Dr. Biggar has been the Independent Chairman of the Board of ACADIA Pharmaceuticals Inc. since June 10, 2016 and serves on the board of Vivelix Pharmaceuticals, Ltd. He has been an Independent Director of ACADIA Pharmaceuticals Inc. since January 2013. He served as a Director of Synageva BioPharma Corp. from May 2004 to June 22, 2015. He serves as an Independent Director at Kiniksa Pharmaceuticals International, plc (formerly known as Kiniksa Pharmaceuticals, Ltd.) Since October 2015. He served as a Director of BioCryst Pharmaceuticals Inc. from October 5, 2005 to October 2011. He holds an M.D. and a Ph.D. degrees in Immunology from Stanford University. He holds a B.S. degree in Genetics from the University of Rochester.

Positions